Gaurav Shah Net Worth & Insider Trades

Gaurav Shah - CEO, Rocket Pharmaceuticals, Inc

As of February 16, 2022

What is Gaurav Shah's Net Worth?

The current estimated net worth of Rocket Pharmaceuticals, Inc's CEO, Gaurav Shah, is estimated to be about $13.97M . Gaurav Shah owns about 715,980 units of Rocket Pharmaceuticals, Inc common stock. In the last 4 years at Rocket Pharmaceuticals, Inc, Gaurav Shah has sold an estimated value of $10.85M worth.

What is Gaurav Shah's Past Insider Trading?

Gaurav Shah's largest purchase order was 22,000 units , worth over $381.51K on February 8, 2022. Gaurav Shah's largest sale order was 74,900 units , worth over $1.29M on March 5, 2019. In total, Gaurav Shah has made about 11 transactions over 4 years of their time at Rocket Pharmaceuticals, Inc. Gaurav Shah usually trades in February, with the busiest year in 2020 and 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Gaurav Shah's Salary in 2020?

The vast majority of their compensation came in the form of other earnings, plans or compensations of $6,859,135 , option awards of $5,821,735 , and other compensation of $11,400 .

What is Gaurav Shah's' Mailing Address?

  • Mailing address is 430 East 29th Street Suite 1040 New York NY 10016 NY

Rocket Pharmaceuticals, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Other Earnings Plans or Compensations
Gaurav D. Shah, M.D. 2020 $6,859,135 $6,859,135 $5,821,735 $11,400 $6,859,135
Gaurav D. Shah, M.D. 2019 $3,883,646 $3,883,646 $3,043,306 $11,200 $3,883,646
Gaurav D. Shah, M.D. 2018 $6,375,752 $6,375,752 $5,651,220 $9,857 $6,375,752
Kinnari Patel, Pharm.D., MBA 2020 $4,080,621 $4,080,621 $3,254,721 $11,400 $4,080,621
Kinnari Patel, Pharm.D., MBA 2019 $2,776,209 $2,776,209 $2,092,294 $11,200 $2,776,209
Kinnari Patel, Pharm.D., MBA 2018 $2,991,073 $2,991,073 $2,423,050 $11,066 $2,991,073
Jonathan Schwartz, M.D., 2020 $1,870,733 $1,870,733 $1,251,033 $11,400 $1,870,733
Jonathan Schwartz, M.D., 2019 $1,475,675 $1,475,675 $937,261 $8,165 $1,475,675
Jonathan Schwartz, M.D., 2018 $1,356,675 $1,356,675 $830,761 $8,854 $1,356,675
Kamran Alam 2020 $634,250 $634,250 $427,670 $9,350 $634,250
Kamran Alam 2019 $2,051,457 $2,051,457 $1,916,912 - $2,051,457
John Militello, Controller and Treasurer Principal Controller and Treasurer Principal 2020 $1,003,053 $1,003,053 $617,270 $11,400 $1,003,053
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1281895/000114036121015285/nc10023585x1_def14a.htm

What are Rocket Pharmaceuticals, Inc's Past Insider Trades?

Rocket Pharmaceuticals, Inc's most recent insider trade came on October 11, 2022 by Rtw Investments Lp and Roderick Wong who bought 1,355,932 units worth $20M . In the last 4 years, insiders at Rocket Pharmaceuticals, Inc have sold an estimated value of $44.68M and bought an estimated value of $92.53M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Roderick Wong, Director,  Naveen Yalamanchi,  and Kinnari Patel, See Remarks .

ROCKET PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1